Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks
Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.
Tax Tech Market worth $36.72 billion by 2030- Exclusive Report by MarketsandMarkets
The global Tax Tech Market will grow from USD 18.53 billion in 2024 to USD 36.72 billion by 2030 at a compounded annual growth rate (CAGR) ...
Tax Tech Market worth $36.72 billion by 2030- Exclusive Report by MarketsandMarkets™
The global Tax Tech Market will grow from USD 18.53 billion in 2024 to USD 36.72 billion by 2030 at a compounded annual ...
Vertex: Expectations Reset With Improved Fundamentals (Rating Upgrade)
Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...
Vertex Commerce Study: Returnuary’s Growing Complexity Forces Retailers to Keep Pace
Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of indirect tax technology solutions, reveals that while free, easy product returns are paramount for consumer loyalty, they ...
Investing18d
Vertex’s SWOT analysis: stock poised for growth amid tax tech boom
Vertex has established itself as a frontrunner in the indirect tax automation space, serving over 4,800 customers, including more than 60% of the Fortune 500. The company’s solutions are utilized in ...
Electrek18d
Tesla confirms it can’t sell the Cybertruck even with tax credit and discounts
Tesla has revealed Cybertruck deliveries in the US, confirming that it can’t sell the electric truck even with federal tax credits and discounts. As we previously reported, Tesla is highly ...
Investing19d
Vertex’s SWOT analysis: stock poised for growth amid tax tech boom
Vertex has established itself as a frontrunner in the indirect tax automation space, serving over 4,800 customers, including more than 60% of the Fortune 500. The company’s solutions are ...